Encyclopedia of Experiments: Cancer Research
A subscription to JoVE is required to view this content.
Transcript
miRNA inhibitors are small, chemically modified single-stranded RNA molecules that bind to endogenous miRNA and repress its activity.
To model the effect of intratumoral treatment using miRNA inhibitors, begin by taking a suspension of bioluminescent enzyme-tagged cancer cells. Add a liquified basement membrane matrix to the cancer cell suspension.
Load the resulting mixture into a syringe. Inject it subcutaneously into the left flank of an immunodeficient nude mouse. Allow the cancer cells to grow and form a tumor.
Concomitantly, prepare a treatment mix by adding lipid nanoparticles - an in-vivo delivery agent - to the tube containing miRNA-inhibitor solution. Incubate the treatment mix to allow the encapsulation of miRNA-inhibitors into the lipid nanoparticles.
Inject the treatment mix directly into the tumor. Lipid nanoparticles deliver miRNA-inhibitors inside the tumor cell. Once inside, miRNA-inhibitors bind to specific oncogenic miRNAs, preventing them from hybridizing to their target mRNAs. This leads to the death of cancer cells.
Finally, inject a bioluminescent substrate solution subcutaneously into the mouse. In the presence of bioluminescence enzymes, the substrate in cancer cells oxidizes with subsequent light emission.
Visualize the mouse using a bioluminescence imaging chamber. Intratumorally injected miRNA-inhibitors significantly suppress tumor growth in the mouse.
